Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024
Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024
VANCOUVER, British Columbia, May 08, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, today announced that the company will present at the BofA Securities Health Care Conference 2024 taking place May 14-16, 2024 in Las Vegas, NV.
不列顛哥倫比亞省溫哥華，2024年5月8日（GLOBE NEWSWIRE）——專注於神經科學的生物製藥公司Xenon Pharmicals Inc.（納斯達克股票代碼：XENE）今天宣佈，該公司將出席2024年5月14日至16日在內華達州拉斯維加斯舉行的2024年美銀證券醫療保健會議。
|
Fireside Chat Presentation Details: | |
| Date: | Wednesday, May 15, 2024 |
| Time: | 3:40 pm Pacific Time (6:40 pm Eastern Time) |
| Webcast: | Register here |
| Presenters: | Ian Mortimer, President and Chief Executive Officer Sherry Aulin, Chief Financial Officer |
| 爐邊聊天演示詳情： | |
| 日期： | 2024年5月15日，星期三 |
| 時間： | 太平洋時間下午 3:40（東部時間下午 6:40） |
| 網絡直播： | 在這裏註冊 |
| 主持人： | 伊恩·莫蒂默，總裁兼首席執行官 雪莉·奧林，首席財務官 |
A live webcast of the company presentation will be available on the "Investors" section of Xenon's website and posted for replay following the event. The above listed dates and times are subject to change.
公司演講的網絡直播將在Xenon網站的 “投資者” 部分播出，並在活動結束後發佈以供重播。上面列出的日期和時間可能會發生變化。
About Xenon Pharmaceuticals Inc.
關於Xenon Pharmicals Inc
Xenon Pharmaceuticals (Nasdaq:XENE) is a neuroscience-focused biopharmaceutical company committed to discovering, developing, and commercializing innovative therapeutics to improve the lives of people living with neurological and psychiatric disorders. We are advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. For more information, please visit .
Xenon Pharmicals（納斯達克股票代碼：XENE）是一家專注於神經科學的生物製藥公司，致力於發現、開發和商業化創新療法，以改善神經系統和精神疾病患者的生活。我們正在推進新的產品線，以解決包括癲癇和抑鬱症在內的未得到滿足的高度醫療需求領域。欲了解更多信息，請訪問。
"Xenon" and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.
“Xenon” 和 Xenon 徽標是 Xenon Pharmicals Inc. 在各個司法管轄區的註冊商標或商標。所有其他商標均屬於其各自所有者。
Contacts:
For Investors:
Chad Fugere
Vice President, Investor Relations
(857) 675-7275
investors@xenon-pharma.com
聯繫人：
對於投資者：
Chad Fugere
投資者關係副總裁
(857) 675-7275
investors@xenon-pharma.com
For Media:
Jodi Regts
Xenon Corporate Affairs
(604) 484-3353
media@xenon-pharma.com
對於媒體：
喬迪·雷格斯
Xenon 企業事務
(604) 484-3353
media@xenon-pharma.com
譯文內容由第三人軟體翻譯。